Navigation Links
Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
Date:12/4/2012

SAN DIEGO, Dec. 4, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will provide details of obesity therapeutics market research including the results of surveys of 1,000 physicians and 6,000 patients during an Analyst Day event on December 18, 2012. The Company will also provide an update to the Contrave® Light Study and discuss U.S. and EU regulatory planning.

The Analyst Day event will be held in New York City on December 18, 2012 from 9 a.m. to 12 p.m. Eastern Time.

While attendance in person is by invitation only, Orexigen will webcast the Analyst Day presentations. The webcast can be accessed live on the Investor Relations section of the Orexigen website at www.orexigen.com and will be archived for 14 days following the call.

About Orexigen Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.
 

Source:
Orexigen Therapeutics
McDavid Stilwell
Vice President, Corporate Communications & Business Development
858-875-8600


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
2. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
3. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
4. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
7. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
8. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
9. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
10. Flexion Therapeutics Secures $20 Million in Series B Financing
11. Echo Therapeutics Announces Proposed Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2020)... Fla. (PRWEB) , ... June 23, 2020 , ... One ... II, Ph.D. is working to prove a similar, universal program does not work as ... coronavirus COVID-19 has affected nearly everyone’s daily life in one way or another, from ...
(Date:6/19/2020)... KANSAS CITY, Mo. (PRWEB) , ... June 19, 2020 , ... ... health and end hunger in individuals diagnosed with food allergies and celiac disease announced ... & Food Allergy. , This webinar is scheduled for Friday, June 19, 2020, ...
(Date:6/19/2020)... ... June 19, 2020 , ... ... Index (EGRI) , a comprehensive recovery index that combines three sub-indices that COVID-19 ... index seeks to provide a holistic way of looking at these three areas ...
Breaking Medicine Technology:
(Date:7/1/2020)... ... July 01, 2020 , ... ABSTRAX, an industry leader ... its new terpene infused product line including custom rolling papers, cones, flat ... terpene profiles and flavors worldwide. , “We’ve made it easier than ever for ...
(Date:6/28/2020)... ... June 26, 2020 , ... The ... the revision and redesignation of the ANSI/APSP/ICC-7 2013 American National Standard for Suction ... PHTA is seeking member participation on the PHTA-7 Standard Writing Committee (SWC) for ...
(Date:6/28/2020)... ... June 26, 2020 , ... The ... the general public. As a supplier of top-quality masks, sanitizers and thermometers, Trusted ... PPE equipment. President Priya Agarwal observed, “All of our masks are manufactured to ...
(Date:6/25/2020)... ... 2020 , ... Pivot Point Consulting, a national healthcare IT ... its telehealth services to provide end-to-end solutions from strategy to platform ... Magazine “2020 Women Leaders in Technology” award winner, Laura Kreofsky , Advisory ...
(Date:6/24/2020)... ... , ... Dr. Katinka van der Merwe, the creator of the world’s leading ... Grit and Grace podcast. She explains her outside-the-box, holistic approach to treating CRPS and ... After being diagnosed with CRPS about 10 years ago, Amberly Lago , the ...
Breaking Medicine News(10 mins):